TY - JOUR AU - Bray, F. AU - Ferlay, J. AU - Soerjomataram, I. AU - Siegel, R. L. AU - Torre, L. A. AU - Jemal, A. PY - 2018 DA - 2018// TI - Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries JO - CA Cancer J Clin VL - 68 UR - https://doi.org/10.3322/caac.21492 DO - 10.3322/caac.21492 ID - Bray2018 ER - TY - JOUR AU - Colagrande, S. AU - Inghilesi, A. L. AU - Aburas, S. AU - Taliani, G. G. AU - Nardi, C. AU - Marra, F. PY - 2016 DA - 2016// TI - Challenges of advanced hepatocellular carcinoma JO - World J Gastroenterol VL - 22 UR - https://doi.org/10.3748/wjg.v22.i34.7645 DO - 10.3748/wjg.v22.i34.7645 ID - Colagrande2016 ER - TY - JOUR AU - Zhao, Y. AU - Shuen, T. W. H. AU - Toh, T. B. AU - Chan, X. Y. AU - Liu, M. AU - Tan, S. Y. PY - 2018 DA - 2018// TI - Development of a new patient-derived xenograft humanised mouse model to study human-specific tumour microenvironment and immunotherapy JO - Gut VL - 67 UR - https://doi.org/10.1136/gutjnl-2017-315201 DO - 10.1136/gutjnl-2017-315201 ID - Zhao2018 ER - TY - JOUR AU - Nishida, N. AU - Kudo, M. PY - 2017 DA - 2017// TI - Immunological microenvironment of hepatocellular carcinoma and its clinical implication JO - Oncology VL - 92 UR - https://doi.org/10.1159/000451015 DO - 10.1159/000451015 ID - Nishida2017 ER - TY - JOUR AU - Wang, L. AU - Wang, F. S. PY - 2019 DA - 2019// TI - Clinical immunology and immunotherapy for hepatocellular carcinoma: current progress and challenges JO - Hepatol Int VL - 13 UR - https://doi.org/10.1007/s12072-019-09967-y DO - 10.1007/s12072-019-09967-y ID - Wang2019 ER - TY - JOUR AU - Chen, D. S. AU - Mellman, I. PY - 2017 DA - 2017// TI - Elements of cancer immunity and the cancer-immune set point JO - Nature VL - 541 UR - https://doi.org/10.1038/nature21349 DO - 10.1038/nature21349 ID - Chen2017 ER - TY - JOUR AU - Mizukoshi, E. AU - Kaneko, S. PY - 2019 DA - 2019// TI - Immune cell therapy for hepatocellular carcinoma JO - J Hematol Oncol VL - 12 UR - https://doi.org/10.1186/s13045-019-0742-5 DO - 10.1186/s13045-019-0742-5 ID - Mizukoshi2019 ER - TY - JOUR AU - Pardoll, D. M. PY - 2012 DA - 2012// TI - The blockade of immune checkpoints in cancer immunotherapy JO - Nat Rev Cancer VL - 12 UR - https://doi.org/10.1038/nrc3239 DO - 10.1038/nrc3239 ID - Pardoll2012 ER - TY - JOUR AU - Sia, D. AU - Jiao, Y. AU - Martinez-Quetglas, I. AU - Kuchuk, O. AU - Villacorta-Martin, C. AU - Moura, M. C. PY - 2017 DA - 2017// TI - Identification of an immune-specific class of hepatocellular carcinoma, based on molecular features JO - Gastroenterology VL - 153 UR - https://doi.org/10.1053/j.gastro.2017.06.007 DO - 10.1053/j.gastro.2017.06.007 ID - Sia2017 ER - TY - JOUR AU - Bruix, J. AU - Reig, M. AU - Sherman, M. PY - 2016 DA - 2016// TI - Evidence-based diagnosis, staging, and treatment of patients with hepatocellular carcinoma JO - Gastroenterology VL - 150 UR - https://doi.org/10.1053/j.gastro.2015.12.041 DO - 10.1053/j.gastro.2015.12.041 ID - Bruix2016 ER - TY - JOUR AU - Xue, C. AU - Zhao, Y. AU - Jiang, J. AU - Li, L. PY - 2020 DA - 2020// TI - Expression levels of lncRNAs are prognostic for hepatocellular carcinoma overall survival JO - Am J Transl Res VL - 12 ID - Xue2020 ER - TY - JOUR AU - He, Y. AU - Yu, X. AU - Li, J. AU - Zhang, Q. AU - Zheng, Q. AU - Guo, W. PY - 2020 DA - 2020// TI - Role of m(5)C-related regulatory genes in the diagnosis and prognosis of hepatocellular carcinoma JO - Am J Transl Res VL - 12 ID - He2020 ER - TY - JOUR AU - He, Y. AU - Dang, Q. AU - Li, J. AU - Zhang, Q. AU - Yu, X. AU - Xue, M. PY - 2020 DA - 2020// TI - Prediction of hepatocellular carcinoma prognosis based on expression of an immune-related gene set JO - Aging (Albany NY) VL - 12 UR - https://doi.org/10.18632/aging.102669 DO - 10.18632/aging.102669 ID - He2020 ER - TY - JOUR AU - Mariathasan, S. AU - Turley, S. J. AU - Nickles, D. AU - Castiglioni, A. AU - Yuen, K. AU - Wang, Y. PY - 2018 DA - 2018// TI - TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells JO - Nature VL - 554 UR - https://doi.org/10.1038/nature25501 DO - 10.1038/nature25501 ID - Mariathasan2018 ER - TY - JOUR AU - Rooney, M. S. AU - Shukla, S. A. AU - Wu, C. J. AU - Getz, G. AU - Hacohen, N. PY - 2015 DA - 2015// TI - Molecular and genetic properties of tumors associated with local immune cytolytic activity JO - Cell VL - 160 UR - https://doi.org/10.1016/j.cell.2014.12.033 DO - 10.1016/j.cell.2014.12.033 ID - Rooney2015 ER - TY - JOUR AU - Chifman, J. AU - Pullikuth, A. AU - Chou, J. W. AU - Bedognetti, D. AU - Miller, L. D. PY - 2016 DA - 2016// TI - Conservation of immune gene signatures in solid tumors and prognostic implications JO - BMC Cancer VL - 16 UR - https://doi.org/10.1186/s12885-016-2948-z DO - 10.1186/s12885-016-2948-z ID - Chifman2016 ER - TY - JOUR AU - Becht, E. AU - Giraldo, N. A. AU - Lacroix, L. AU - Buttard, B. AU - Elarouci, N. AU - Petitprez, F. PY - 2016 DA - 2016// TI - Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression JO - Genome Biol VL - 17 UR - https://doi.org/10.1186/s13059-016-1070-5 DO - 10.1186/s13059-016-1070-5 ID - Becht2016 ER - TY - JOUR AU - Tibshirani, R. PY - 1997 DA - 1997// TI - The lasso method for variable selection in the Cox model JO - Stat Med VL - 16 UR - https://doi.org/3.0.CO;2-3 DO - 3.0.CO;2-3 ID - Tibshirani1997 ER - TY - JOUR AU - Cai, M. Y. AU - Zhang, B. AU - He, W. P. AU - Yang, G. F. AU - Rao, H. L. AU - Rao, Z. Y. PY - 2010 DA - 2010// TI - Decreased expression of PinX1 protein is correlated with tumor development and is a new independent poor prognostic factor in ovarian carcinoma JO - Cancer Sci VL - 101 UR - https://doi.org/10.1111/j.1349-7006.2010.01560.x DO - 10.1111/j.1349-7006.2010.01560.x ID - Cai2010 ER - TY - JOUR AU - Jin, H. AU - Zhang, Y. AU - You, H. AU - Tao, X. AU - Wang, C. AU - Jin, G. PY - 2015 DA - 2015// TI - Prognostic significance of kynurenine 3-monooxygenase and effects on proliferation, migration, and invasion of human hepatocellular carcinoma JO - Sci Rep VL - 5 UR - https://doi.org/10.1038/srep10466 DO - 10.1038/srep10466 ID - Jin2015 ER - TY - JOUR AU - Mootha, V. K. AU - Lindgren, C. M. AU - Eriksson, K. F. AU - Subramanian, A. AU - Sihag, S. AU - Lehar, J. PY - 2003 DA - 2003// TI - PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes JO - Nat Genet VL - 34 UR - https://doi.org/10.1038/ng1180 DO - 10.1038/ng1180 ID - Mootha2003 ER - TY - JOUR AU - Subramanian, A. AU - Tamayo, P. AU - Mootha, V. K. AU - Mukherjee, S. AU - Ebert, B. L. AU - Gillette, M. A. PY - 2005 DA - 2005// TI - Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles JO - Proc Natl Acad Sci U S A VL - 102 UR - https://doi.org/10.1073/pnas.0506580102 DO - 10.1073/pnas.0506580102 ID - Subramanian2005 ER - TY - JOUR AU - Zheng, Y. AU - Liu, Y. AU - Zhao, S. AU - Zheng, Z. AU - Shen, C. AU - An, L. PY - 2018 DA - 2018// TI - Large-scale analysis reveals a novel risk score to predict overall survival in hepatocellular carcinoma JO - Cancer Manag Res VL - 10 UR - https://doi.org/10.2147/CMAR.S181396 DO - 10.2147/CMAR.S181396 ID - Zheng2018 ER - TY - JOUR AU - Ke, K. AU - Chen, G. AU - Cai, Z. AU - Huang, Y. AU - Zhao, B. AU - Wang, Y. PY - 2018 DA - 2018// TI - Evaluation and prediction of hepatocellular carcinoma prognosis based on molecular classification JO - Cancer Manag Res VL - 10 UR - https://doi.org/10.2147/CMAR.S178579 DO - 10.2147/CMAR.S178579 ID - Ke2018 ER - TY - JOUR AU - Liu, G. M. AU - Zeng, H. D. AU - Zhang, C. Y. AU - Xu, J. W. PY - 2019 DA - 2019// TI - Identification of a six-gene signature predicting overall survival for hepatocellular carcinoma JO - Cancer Cell Int VL - 19 UR - https://doi.org/10.1186/s12935-019-0858-2 DO - 10.1186/s12935-019-0858-2 ID - Liu2019 ER - TY - JOUR AU - Miao, Y. R. AU - Zhang, Q. AU - Lei, Q. AU - Luo, M. AU - Xie, G. Y. AU - Wang, H. PY - 2020 DA - 2020// TI - ImmuCellAI: a unique method for comprehensive T-cell subsets abundance prediction and its application in cancer immunotherapy JO - Adv Sci VL - 7 UR - https://doi.org/10.1002/advs.201902880 DO - 10.1002/advs.201902880 ID - Miao2020 ER - TY - JOUR AU - Jurmeister, P. AU - Laffert, M. AU - Jöhrens, K. PY - 2020 DA - 2020// TI - Dissecting the spatial heterogeneity of different immune cell subsets in non-small cell lung cancer JO - Pathol Res Pract VL - 216 UR - https://doi.org/10.1016/j.prp.2020.152904 DO - 10.1016/j.prp.2020.152904 ID - Jurmeister2020 ER - TY - JOUR AU - Zhou, R. AU - Zhang, J. AU - Zeng, D. AU - Sun, H. AU - Rong, X. AU - Shi, M. PY - 2019 DA - 2019// TI - Immune cell infiltration as a biomarker for the diagnosis and prognosis of stage I-III colon cancer JO - Cancer Immunol Immunother VL - 68 UR - https://doi.org/10.1007/s00262-018-2289-7 DO - 10.1007/s00262-018-2289-7 ID - Zhou2019 ER - TY - JOUR AU - Shen, S. AU - Wang, G. AU - Zhang, R. AU - Zhao, Y. AU - Yu, H. AU - Wei, Y. PY - 2019 DA - 2019// TI - Development and validation of an immune gene-set based prognostic signature in ovarian cancer JO - EBioMedicine VL - 40 UR - https://doi.org/10.1016/j.ebiom.2018.12.054 DO - 10.1016/j.ebiom.2018.12.054 ID - Shen2019 ER - TY - JOUR AU - Tekpli, X. AU - Lien, T. AU - Røssevold, A. H. AU - Nebdal, D. AU - Borgen, E. AU - Ohnstad, H. O. PY - 2019 DA - 2019// TI - An independent poor-prognosis subtype of breast cancer defined by a distinct tumor immune microenvironment JO - Nat Commun VL - 10 UR - https://doi.org/10.1038/s41467-019-13329-5 DO - 10.1038/s41467-019-13329-5 ID - Tekpli2019 ER - TY - JOUR AU - Feng, B. AU - Shen, Y. AU - Pastor Hostench, X. AU - Bieg, M. AU - Plath, M. AU - Ishaque, N. PY - 2020 DA - 2020// TI - Integrative analysis of multi-omics data identified EGFR and PTGS2 as key nodes in a gene regulatory network related to immune phenotypes in head and neck cancer JO - Clin Cancer Res VL - 26 UR - https://doi.org/10.1158/1078-0432.CCR-19-3997 DO - 10.1158/1078-0432.CCR-19-3997 ID - Feng2020 ER - TY - JOUR AU - Calderaro, J. AU - Couchy, G. AU - Imbeaud, S. AU - Amaddeo, G. AU - Letouzé, E. AU - Blanc, J. F. PY - 2017 DA - 2017// TI - Histological subtypes of hepatocellular carcinoma are related to gene mutations and molecular tumour classification JO - J Hepatol VL - 67 UR - https://doi.org/10.1016/j.jhep.2017.05.014 DO - 10.1016/j.jhep.2017.05.014 ID - Calderaro2017 ER - TY - JOUR AU - Nault, J. C. AU - Martin, Y. AU - Caruso, S. AU - Hirsch, T. Z. AU - Bayard, Q. AU - Calderaro, J. PY - 2020 DA - 2020// TI - Clinical impact of genomic diversity from early to advanced hepatocellular carcinoma JO - Hepatology VL - 71 UR - https://doi.org/10.1002/hep.30811 DO - 10.1002/hep.30811 ID - Nault2020 ER - TY - JOUR AU - Guichard, C. AU - Amaddeo, G. AU - Imbeaud, S. AU - Ladeiro, Y. AU - Pelletier, L. AU - Maad, I. B. PY - 2012 DA - 2012// TI - Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma JO - Nat Genet VL - 44 UR - https://doi.org/10.1038/ng.2256 DO - 10.1038/ng.2256 ID - Guichard2012 ER - TY - JOUR AU - Schulze, K. AU - Imbeaud, S. AU - Letouzé, E. AU - Alexandrov, L. B. AU - Calderaro, J. AU - Rebouissou, S. PY - 2015 DA - 2015// TI - Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets JO - Nat Genet VL - 47 UR - https://doi.org/10.1038/ng.3252 DO - 10.1038/ng.3252 ID - Schulze2015 ER - TY - JOUR AU - Totoki, Y. AU - Tatsuno, K. AU - Covington, K. R. AU - Ueda, H. AU - Creighton, C. J. AU - Kato, M. PY - 2014 DA - 2014// TI - Trans-ancestry mutational landscape of hepatocellular carcinoma genomes JO - Nat Genet VL - 46 UR - https://doi.org/10.1038/ng.3126 DO - 10.1038/ng.3126 ID - Totoki2014 ER - TY - JOUR AU - Nault, J. C. AU - Calderaro, J. AU - Tommaso, L. AU - Balabaud, C. AU - Zafrani, E. S. AU - Bioulac-Sage, P. PY - 2014 DA - 2014// TI - Telomerase reverse transcriptase promoter mutation is an early somatic genetic alteration in the transformation of premalignant nodules in hepatocellular carcinoma on cirrhosis JO - Hepatology VL - 60 UR - https://doi.org/10.1002/hep.27372 DO - 10.1002/hep.27372 ID - Nault2014 ER - TY - JOUR AU - Rao, C. V. AU - Asch, A. S. AU - Yamada, H. Y. PY - 2017 DA - 2017// TI - Frequently mutated genes/pathways and genomic instability as prevention targets in liver cancer JO - Carcinogenesis VL - 38 UR - https://doi.org/10.1093/carcin/bgw118 DO - 10.1093/carcin/bgw118 ID - Rao2017 ER - TY - JOUR AU - Chalmers, Z. R. AU - Connelly, C. F. AU - Fabrizio, D. AU - Gay, L. AU - Ali, S. M. AU - Ennis, R. PY - 2017 DA - 2017// TI - Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden JO - Genome Med VL - 9 UR - https://doi.org/10.1186/s13073-017-0424-2 DO - 10.1186/s13073-017-0424-2 ID - Chalmers2017 ER - TY - JOUR AU - Yarchoan, M. AU - Hopkins, A. AU - Jaffee, E. M. PY - 2017 DA - 2017// TI - Tumor mutational burden and response rate to PD-1 inhibition JO - N Engl J Med VL - 377 UR - https://doi.org/10.1056/NEJMc1713444 DO - 10.1056/NEJMc1713444 ID - Yarchoan2017 ER - TY - JOUR AU - Cai, H. AU - Zhang, Y. AU - Zhang, H. AU - Cui, C. AU - Li, C. AU - Lu, S. PY - 2020 DA - 2020// TI - Prognostic role of tumor mutation burden in hepatocellular carcinoma after radical hepatectomy JO - J Surg Oncol VL - 121 UR - https://doi.org/10.1002/jso.25859 DO - 10.1002/jso.25859 ID - Cai2020 ER - TY - JOUR AU - Stenzinger, A. AU - Allen, J. D. AU - Maas, J. AU - Stewart, M. D. AU - Merino, D. M. AU - Wempe, M. M. PY - 2019 DA - 2019// TI - Tumor mutational burden standardization initiatives: Recommendations for consistent tumor mutational burden assessment in clinical samples to guide immunotherapy treatment decisions JO - Genes Chromosomes Cancer VL - 58 UR - https://doi.org/10.1002/gcc.22733 DO - 10.1002/gcc.22733 ID - Stenzinger2019 ER - TY - JOUR AU - Linnemann, C. AU - Buuren, M. M. AU - Bies, L. AU - Verdegaal, E. M. AU - Schotte, R. AU - Calis, J. J. PY - 2015 DA - 2015// TI - High-throughput epitope discovery reveals frequent recognition of neo-antigens by CD4+ T cells in human melanoma JO - Nat Med VL - 21 UR - https://doi.org/10.1038/nm.3773 DO - 10.1038/nm.3773 ID - Linnemann2015 ER - TY - JOUR AU - Bulk, J. AU - Verdegaal, E. M. AU - Miranda, N. F. PY - 2018 DA - 2018// TI - Cancer immunotherapy: broadening the scope of targetable tumours JO - Open Biol VL - 8 UR - https://doi.org/10.1098/rsob.180037 DO - 10.1098/rsob.180037 ID - Bulk2018 ER - TY - JOUR AU - Iwahana, H. AU - Oka, J. AU - Mizusawa, N. AU - Kudo, E. AU - Ii, S. AU - Yoshimoto, K. PY - 1993 DA - 1993// TI - Molecular cloning of human amidophosphoribosyltransferase JO - Biochem Biophys Res Commun VL - 190 UR - https://doi.org/10.1006/bbrc.1993.1030 DO - 10.1006/bbrc.1993.1030 ID - Iwahana1993 ER - TY - JOUR AU - Yamaoka, T. AU - Kondo, M. AU - Honda, S. AU - Iwahana, H. AU - Moritani, M. AU - Ii, S. PY - 1997 DA - 1997// TI - Amidophosphoribosyltransferase limits the rate of cell growth-linked de novo purine biosynthesis in the presence of constant capacity of salvage purine biosynthesis JO - J Biol Chem VL - 272 UR - https://doi.org/10.1074/jbc.272.28.17719 DO - 10.1074/jbc.272.28.17719 ID - Yamaoka1997 ER - TY - JOUR AU - Bibi, N. AU - Parveen, Z. AU - Nawaz, M. S. AU - Kamal, M. A. PY - 2019 DA - 2019// TI - In silico structure modeling and molecular docking analysis of phosphoribosyl pyrophosphate amidotransferase (PPAT) with antifolate inhibitors JO - Curr Cancer Drug Targets VL - 19 UR - https://doi.org/10.2174/1568009619666181127115015 DO - 10.2174/1568009619666181127115015 ID - Bibi2019 ER - TY - JOUR AU - Hu, X. AU - Bao, M. AU - Huang, J. AU - Zhou, L. AU - Zheng, S. PY - 2020 DA - 2020// TI - Identification and validation of novel biomarkers for diagnosis and prognosis of hepatocellular carcinoma JO - Front Oncol VL - 10 UR - https://doi.org/10.3389/fonc.2020.541479 DO - 10.3389/fonc.2020.541479 ID - Hu2020 ER - TY - JOUR AU - Yu, C. AU - Hou, L. AU - Cui, H. AU - Zhang, L. AU - Tan, X. AU - Leng, X. PY - 2018 DA - 2018// TI - LDHA upregulation independently predicts poor survival in lung adenocarcinoma, but not in lung squamous cell carcinoma JO - Future Oncol VL - 14 UR - https://doi.org/10.2217/fon-2018-0177 DO - 10.2217/fon-2018-0177 ID - Yu2018 ER - TY - JOUR AU - Guddeti, R. K. AU - Bali, P. AU - Karyala, P. AU - Pakala, S. B. PY - 2019 DA - 2019// TI - MTA1 coregulator regulates LDHA expression and function in breast cancer JO - Biochem Biophys Res Commun VL - 520 UR - https://doi.org/10.1016/j.bbrc.2019.09.078 DO - 10.1016/j.bbrc.2019.09.078 ID - Guddeti2019 ER - TY - JOUR AU - Hua, S. AU - Liu, C. AU - Liu, L. AU - Wu, D. PY - 2018 DA - 2018// TI - miR-142-3p inhibits aerobic glycolysis and cell proliferation in hepatocellular carcinoma via targeting LDHA JO - Biochem Biophys Res Commun VL - 496 UR - https://doi.org/10.1016/j.bbrc.2018.01.112 DO - 10.1016/j.bbrc.2018.01.112 ID - Hua2018 ER - TY - JOUR AU - He, Y. AU - Chen, X. AU - Yu, Y. AU - Li, J. AU - Hu, Q. AU - Xue, C. PY - 2018 DA - 2018// TI - LDHA is a direct target of miR-30d-5p and contributes to aggressive progression of gallbladder carcinoma JO - Mol Carcinog VL - 57 UR - https://doi.org/10.1002/mc.22799 DO - 10.1002/mc.22799 ID - He2018 ER - TY - JOUR AU - Zhao, J. AU - Huang, X. AU - Xu, Z. AU - Dai, J. AU - He, H. AU - Zhu, Y. PY - 2017 DA - 2017// TI - LDHA promotes tumor metastasis by facilitating epithelial-mesenchymal transition in renal cell carcinoma JO - Mol Med Rep VL - 16 UR - https://doi.org/10.3892/mmr.2017.7637 DO - 10.3892/mmr.2017.7637 ID - Zhao2017 ER - TY - JOUR AU - Lu, Y. AU - Liu, Y. AU - Liao, S. AU - Tu, W. AU - Shen, Y. AU - Yan, Y. PY - 2016 DA - 2016// TI - Epigenetic modifications promote the expression of the orphan nuclear receptor NR0B1 in human lung adenocarcinoma cells JO - Oncotarget VL - 7 UR - https://doi.org/10.18632/oncotarget.9012 DO - 10.18632/oncotarget.9012 ID - Lu2016 ER - TY - JOUR AU - Döpke, W. AU - Schwertner, E. AU - Wagner, J. AU - Flöther, F. PY - 1990 DA - 1990// TI - Resolution of racemates of the beta-receptor blocker propranolol JO - Pharmazie VL - 45 ID - Döpke1990 ER - TY - JOUR AU - Kinsey, M. AU - Smith, R. AU - Iyer, A. K. AU - McCabe, E. R. AU - Lessnick, S. L. PY - 2009 DA - 2009// TI - EWS/FLI and its downstream target NR0B1 interact directly to modulate transcription and oncogenesis in Ewing's sarcoma JO - Cancer Res VL - 69 UR - https://doi.org/10.1158/0008-5472.CAN-09-1540 DO - 10.1158/0008-5472.CAN-09-1540 ID - Kinsey2009 ER - TY - JOUR AU - Kinsey, M. AU - Smith, R. AU - Lessnick, S. L. PY - 2006 DA - 2006// TI - NR0B1 is required for the oncogenic phenotype mediated by EWS/FLI in Ewing's sarcoma JO - Mol Cancer Res VL - 4 UR - https://doi.org/10.1158/1541-7786.MCR-06-0090 DO - 10.1158/1541-7786.MCR-06-0090 ID - Kinsey2006 ER - TY - JOUR AU - Minchenko, O. AU - Tsuchihara, K. AU - Minchenko, D. AU - Bikfalvi, A. AU - Esumi, H. PY - 2014 DA - 2014// TI - Mechanisms of regulation of PFKFB expression in pancreatic and gastric cancer cells JO - World J Gastroenterol VL - 20 UR - https://doi.org/10.3748/wjg.v20.i38.13705 DO - 10.3748/wjg.v20.i38.13705 ID - Minchenko2014 ER - TY - JOUR AU - Yun, S. J. AU - Jo, S. W. AU - Ha, Y. S. AU - Lee, O. J. AU - Kim, W. T. AU - Kim, Y. J. PY - 2012 DA - 2012// TI - PFKFB4 as a prognostic marker in non-muscle-invasive bladder cancer JO - Urol Oncol VL - 30 UR - https://doi.org/10.1016/j.urolonc.2010.08.018 DO - 10.1016/j.urolonc.2010.08.018 ID - Yun2012 ER - TY - JOUR AU - Minchenko, O. AU - Ochiai, A. AU - Opentanova, I. AU - Ogura, T. AU - Minchenko, D. AU - Caro, J. PY - 2005 DA - 2005// TI - Overexpression of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-4 in the human breast and colon malignant tumors JO - Biochimie VL - 87 UR - https://doi.org/10.1016/j.biochi.2005.04.007 DO - 10.1016/j.biochi.2005.04.007 ID - Minchenko2005 ER - TY - JOUR AU - Wang, G. AU - Li, S. AU - Xue, K. AU - Dong, S. PY - 2020 DA - 2020// TI - PFKFB4 is critical for the survival of acute monocytic leukemia cells JO - Biochem Biophys Res Commun VL - 526 UR - https://doi.org/10.1016/j.bbrc.2020.03.174 DO - 10.1016/j.bbrc.2020.03.174 ID - Wang2020 ER - TY - JOUR AU - Goidts, V. AU - Bageritz, J. AU - Puccio, L. AU - Nakata, S. AU - Zapatka, M. AU - Barbus, S. PY - 2012 DA - 2012// TI - RNAi screening in glioma stem-like cells identifies PFKFB4 as a key molecule important for cancer cell survival JO - Oncogene VL - 31 UR - https://doi.org/10.1038/onc.2011.490 DO - 10.1038/onc.2011.490 ID - Goidts2012 ER - TY - JOUR AU - Lu, H. AU - Chen, S. AU - You, Z. AU - Xie, C. AU - Huang, S. AU - Hu, X. PY - 2020 DA - 2020// TI - PFKFB4 negatively regulated the expression of histone acetyltransferase GCN5 to mediate the tumorigenesis of thyroid cancer JO - Dev Growth Differ VL - 62 UR - https://doi.org/10.1111/dgd.12645 DO - 10.1111/dgd.12645 ID - Lu2020 ER - TY - JOUR AU - Yao, L. AU - Wang, L. AU - Cao, Z. AU - Hu, X. AU - Shao, Z. PY - 2019 DA - 2019// TI - High expression of metabolic enzyme PFKFB4 is associated with poor prognosis of operable breast cancer JO - Cancer Cell Int VL - 19 UR - https://doi.org/10.1186/s12935-019-0882-2 DO - 10.1186/s12935-019-0882-2 ID - Yao2019 ER - TY - JOUR AU - Gao, R. AU - Liu, Y. AU - Li, D. AU - Xun, J. AU - Zhou, W. AU - Wang, P. PY - 2018 DA - 2018// TI - PFKFB4 promotes breast cancer metastasis via induction of hyaluronan production in a p38-dependent manner JO - Cell Physiol Biochem VL - 50 UR - https://doi.org/10.1159/000495055 DO - 10.1159/000495055 ID - Gao2018 ER - TY - JOUR AU - Dasgupta, S. AU - Rajapakshe, K. AU - Zhu, B. AU - Nikolai, B. C. AU - Yi, P. AU - Putluri, N. PY - 2018 DA - 2018// TI - Metabolic enzyme PFKFB4 activates transcriptional coactivator SRC-3 to drive breast cancer JO - Nature VL - 556 UR - https://doi.org/10.1038/s41586-018-0018-1 DO - 10.1038/s41586-018-0018-1 ID - Dasgupta2018 ER -